The top 10 drug launches of 2019
J&J’s Darzalex pads blockbuster sales with another myeloma nod in new patients
Clinical Catch-up for June 10-14
AbbVie pads Humira follow-up Skyrizi’s blockbuster potential with positive 2-year data
Top 10 pharmaceutical companies to work for according to Glassdoor
ASCO: J&J eyes Darzalex convenience, safety boost with subcutaneous win
J&J’s Invokana closes in on badly needed kidney disease nod with FDA ‘priority’ boost
J&J targets different audiences with Xarelto TV commercial trio
Can Pfizer get Xeljanz, Xtandi pumping while it waits for pipeline help?
The top 15 pharma companies by 2018 revenue
Top 15 Best-Selling Drugs of 2018
Novartis slaps J&J with Tremfya lawsuit, claiming it ‘cherry-picked’ safety stats
Allergan’s Depression Treatment Will Not Hit Endpoints in Late-Stage Trial
Top Clinical Trial Failures of 2018
J&J Earns Spot in Fortune’s Top 50 Most Respected Companies
Are the big corporate venture arms retreating?